Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-14-000042
Filing Date
2014-08-07
Accepted
2014-08-07 13:00:42
Documents
4
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 6-K secondquarter20146k.htm 6-K 23193
2 INTERIM FINANCIAL STATEMENTS JUNE 30, 2014 ex991interimfinancialstate.htm EX-99.1 372978
3 MD&A JUNE 30, 2014 ex992-q22014mda.htm EX-99.2 232921
4 image0a01.jpg GRAPHIC 32654
  Complete submission text file 0001129928-14-000042.txt   675214
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 141022785
SIC: 2834 Pharmaceutical Preparations